Monocyte chemotactic and activating factor (MCAF) is a recently cloned cytokine that causes chemotaxis of basophils. In our pursuit of cytokines affecting basophil function, we studied the effect of MCAF on histamine secretion from basophils. Leukocytes from 20 donors, 10 allergic and 10 normal subjects, were studied. MCAF caused dose-dependent release of histamine at concentrations of i0' and 10-7 M, and the mean release was 31.25±2.9% at the highest concentration. In the same experiments the mean histamine release by anti-IgE and histamine releasing factor (HRF) was 27.05±4% and 32.70±2.7%, respectively. All 20 subjects responded to MCAF with significant histamine release. Allergic subjects released significantly more histamine than normals in response to anti-IgE (P < 0.01) but not to MCAF (P = 0.2) and HRF (P = 0.1). The histamine release was significantly correlated between MCAF and HRF (P < 0.01), but not between MCAF and anti-IgE (P > 0.05). The histamine release by MCAF was complete within the first 3 min. MCAF-induced degranulation was a calcium-dependent process. Leukocytes depleted of monocytes responded equally well to MCAF. Using an anti-MCAF affinity column we determined that > 50% of HRF activity of crude PBMC supernatant could be attributed to MCAF. Thus, we established that MCAF is a potent secretagogue for basophils. (J. Clin. Invest.
Introduction
Chronic allergy is characterized by infiltration ofthe tissue with various inflammatory cells, including eosinophils, mast cells, basophils, lymphocytes, and neutrophils. This allergic inflammation is reminiscent of the late phase reaction to allergen challenge under experimental conditions. A growing body of evidence suggests that cytokines may play a crucial role in the recruitment and activation of inflammatory cells. Increased expression of various cytokines has been demonstrated in tissue specimens from late phase allergic reactions (1) . Cytokines that activate basophils include IL-3, granulocyte macrophagecolony-stimulating factor (GM-CSF) and connective tissue activating peptide III/neutrophil activating peptide-2 (2, 3). Some less defined histamine-releasing factors apparently distinct from most known cytokines have been described and are being characterized. One form of histamine releasing factor (HRF) has been previously found to coelute from various chromatographic columns with basophil chemotactic factor (4) . Also, monocyte chemotactic factor showed a similar chromatographic elution profile as did basophil chemotactic factor (5) . Therefore, we decided to study whether the recently cloned monocyte chemotactic and activating factor (MCAF)/monocyte chemoattractant protein-1 (6, 7) releases histamine from basophils. We also compared the activity of MCAF with HRF and anti-IgE antibody.
Materials and Methods
Reagents. RPMI 1640 was obtained from Gibco Laboratories, Grand Island, NY; HSA, glutamine, Histopaque-1077, Con A, penicillin, streptomycin, FMLP, and C5a from Sigma Chemical Co., St. Louis, MO; Hepes from Research Organics, Inc., Cleveland, OH; hydroxyethyl starch (HetaStarch) from American McGaw, Irvine, CA; MCAF was from PeproTech Inc., Rocky Hills, NJ. The material was 99% pure by SDS-PAGE and reverse phase HPLC. It was received as a Iyophilized material in PBS. A stock solution of MCAF was made at a concentration of 2 X 10-6 M in Hepes-buffered saline, pH 7.4 containing 0.3% HSA, 2 mM CaC12, and 1 mM MgCI2. Affinity-purified rabbit anti-human IgE serum (1 mg/ml) was from Behring Diagnostics, Somerville, NY. Hunter's Titermax was obtained from CytRx Corp., Norcross, GA.
Generation ofHRF-containing supernatant. Leukocytes were isolated from buffy coats obtained from normal blood bank donors. PBMC were isolated by Ficoll-Hypaque gradient centrifugation as previously described (8) and pulsed with Con A 25 ug/ml in RPMI 1640 medium for 12 h, resuspended in RPMI 1640 medium, and then cultured for 72 h. Supernatants were harvested and concentrated 50x using an ultrafiltration chamber with YM-5 filters (mol wt cutoff 5,000; Amicon, Beverly, MA) and ultracentrifuged. Samples were aliquoted, frozen at -70°C, and used as a source of HRF. Samples of HRF were preincubated with 0.02 M alpha-methyl mannoside for 30 min before use. The concentration ofprotein in this preparation was 8 Lg/ml.
Isolation ofperipheral blood leukocytes. Donors for this study were selected from a large group ofallergic and nonallergic subjects that were screened in our laboratory for histamine release from basophils in response to HRF and anti-IgE. Allergic status was defined by the presence ofclinical symptoms, past allergic history, and positive reaction to prick skin testing with a panel of 32 local aeroallergens.
Venous blood from donors was anticoagulated with 10mM EDTA and sedimented with 1.5% hydroxyethyl starch for 30 min at room temperature (8) . The leukocyte-rich buffy coat was collected and washed three times in HA buffer (Hepes-buffered saline, pH 7.4 and 0.03% HSA) in a refrigerated centrifuge (40C) at 300 g. The washed leukocytes were suspended in HACM buffer (Hepes-buffered saline, pH 7.4,0.03% HSA, 2 mM CaCl2, and 1 mM MgCI2). Leukocytes from 1 ml of blood were usually used for one duplicate experiment.
In some experiments mononuclear cells containing 1-2% basophils were purified by Ficoll-Hypaque gradient centrifugation and further processed for use in the histamine release test. To study the effect of depletion of monocytes on MCAF-induced histamine release from basophils, mononuclear cells were suspended in RPMI 1640 with 0.1% HSA and incubated on plastic petri dishes for 1 h at 370C as described previously (8) . Nonadhered cells were collected, washed, and used in the histamine release test. The cells were stained with OKM I antibody followed by FITC-labelled goat anti-mouse IgG to check the percentage of monocytes. The contamination with monocytes was < 2%. In parallel experiments mononuclear cells that were incubated in the same medium for 1 h in a polypropylene tube were used as a control (10-20% monocytes). The symptoms of rhinitis and asthma. The other 10 donors were normal by the same criteria. The mean percentage ofhistamine released by MCAF, anti-IgE, and HRF was 34.7+4. 1%, 37.8±4.8%, and 37.2±3.5%, respectively, in the allergic group, and 27.0±3.5%, 16+4.8%, and 28.6±4.1%, respectively, in the normal group (Fig. 2) . The difference in IgE-induced release was statistically significant between the two groups (P = 0.01, Wilcoxon's rank sum test) but the difference was not significant for MCAF and HRF although both showed a tendency toward a higher release in the allergic group (P = 0.2 for MCAF, P = 0.1 for HRF). There was a significant correlation of histamine release between MCAF and HRF (Fig. 3, A and  B) . The correlation coefficient (r) was 0.73 at the lower concentration, and 0.56 at the higher concentration of MCAF and HRF by Spearman's rank correlation (P < 0.01). No such correlation was found between MCAF and anti-IgE (r = 0. 19 or lower at all concentrations analyzed, P > 0.05).
The kinetics of histamine release by MCAF are shown in Fig. 4 . The release was very rapid, and > 80% of the maximal release took place within 30 s. The release was almost complete A within the first 3 min. HRF showed a similar kinetics profile.
On the other hand, IgE consistently required a lag period of 1-3 min before any noticeable release occurred. To investigate whether the degranulation ofbasophils by MCAF is a calciumdependent phenomenon, we conducted the experiments in Hepes-albumin buffer in the presence of 4 mM EDTA containing no calcium or magnesium. In parallel experiments leukocytes were incubated with MCAF in the calcium containing HACM buffer. The release of histamine was 0 and 43±3% in the absence or presence of calcium and magnesium, respectively (three duplicate experiments). As anticipated, a similar lack of histamine release was observed with anti-IgE and HRF in parallel experiments (data not shown).
Monocytes have previously been shown to produce HRF (8). Since MCAF is an activator ofmonocytes, it is possible that HRF was released during the incubation and caused histamine release. To address this issue we conducted experiments with mononuclear cell preparations depleted of monocytes. Parallel experiments were carried out with cells containing monocytes. As shown in Fig. 5 , the depletion of monocytes did not affect the histamine release from basophils.
Some forms of HRF have previously been shown to be IgE-dependent (11, 12) . This conclusion was drawn on the basis of the loss of response of basophils upon IgE-stripping with lactic acid. We have conducted similar experiments with MCAF. The IgE-stripped basophils showed a significant reduction of histamine release to anti-IgE as well as to HRF and MCAF (Fig. 6) . The response to anti-IgE was restored by both allergic and normal serum. The response to MCAF was restored to a certain degree by sensitization ofthe basophils with serum from two of three allergic patients and two ofthree normal subjects. The response to HRF was partially restored by serum from most donors. The release by FMLP was not affected by the stripping procedure.
Desensitization experiments demonstrated that MCAF desensitized to itselfcompletely within 10 min. A significant selfdesensitization was also observed with anti-IgE and HRF, but required a longer preincubation, for 45 min, and the desensitization was not complete. Preincubation of cells with anti-IgE caused a small but significant cross-desensitization to HRF and MCAF (Fig. 7) . However, the reverse was not true. On the The contribution ofMCAF to the histamine-releasing activity ofthe crude PBMC supernatant was determined by passing the latter through an anti-MCAF affinity column. The affinity column was prepared using purified rabbit polyclonal IgG antibody raised against MCAF. A little more than halfofthe activity was bound to the column and was then eluted with 6 M KSCN (Fig. 8) (3) . Both ofthem release histamine from basophils. As mentioned earlier, IL-3 and GM-CSF cause histamine release from some selected allergic patients (2, 15, 16 (17) . MCAF has no activity on neutrophils and eosinophils. However, it is chemotactic for basophils (10) . Since most chemotactic factors also possess secretagogue activity, our finding on histamine releasing activity of MCAF reinforces this notion. The optimal concentration of MCAF for release of histamine (l1-0 M) was higher than that published for chemotaxis of monocytes in the literature. We verified the activity of our MCAF preparation, and found that the optimal concentration for monocyte chemotaxis was 10-9 M. As mentioned earlier, the activation of monocytes for superoxide generation was found to require concentrations of MCAF higher than that needed for chemotaxis (17) . Similar results were observed with other agonists such as FMLP (18) .
The histamine release experiments with MCAF were conducted with leukocytes containing 0.5-2% basophils. Monocytes have previously been shown to produce HRF (6) . Since MCAF is an activator of monocytes, it is possible that the release of histamine by MCAF is secondary to monocyte-derived HRF. However, we think this unlikely. The action ofMCAF is very rapid, and the release is complete within three minutes. Furthermore, the depletion of monocytes did not affect histamine release by MCAF. However, a definitive answer will require experiments using a homogeneous population ofpurified basophils.
Some species of HRF have been shown to be IgE dependent. The IgE dependency has been defined as the lack of response of IgE-stripped basophils to HRF and the restoration of the response by serum from some allergic patients only. Similar IgE dependency has been demonstrated for IL-3 and D20 (16, 19) . Using the same protocol of lactic acid treatment of basophils we found that the response of basophils to MCAF decreased significantly upon IgE stripping, although the decrease was not as profound as with anti-IgE and HRF. The response was restored with serum from some allergic as well as normal subjects. Similar results were obtained with HRF and anti-IgE. Although the results of IgE-stripping experiments might suggest some IgE dependency of MCAF (and HRF), the results of kinetics experiments, the complete lack of correlation of release between MCAF and anti-IgE, and the good response of normal basophils to MCAF, go against this notion. Although MCAF and PBMC-derived HRF are active on normal basophils, in agreement with MacDonald et al. ( 11) we previously reported that bronchoalveolar lavage-derived HRF was not as active with normal basophils as with basophils from allergic subjects.
The results ofdesensitization experiments were not conclusive. Although anti-IgE partially cross-desensitized MCAF and HRF, the reverse was not true. One possible explanation of these findings would be that both anti-IgE and MCAF have independent intracellular secretory pathways. However, the IgE-mediated secretory pathway may influence MCAF but not vice versa. The lactic acid treatment in the stripping experiment may affect, in addition to IgE, the receptors for some secretagogues, e.g., MCAF, but not FMLP.
Our experiment with the immunoaffinity column established that MCAF significantly contributed to the histamine releasing activity of the crude PBMC supernatant. There was a significant correlation between the release by MCAF and HRF. Also, the kinetics of release by MCAF and HRF were similar. However, a significant proportion of HRF did not bind to the affinity column. MCAF has been identified in several molecular weight forms (10, 13 , and 15 kD) perhaps due to posttranslational modifications. There has been no report of the existence of multimeric forms of MCAF that would resemble the 41-kD HRF species. It is possible that the molecular identity of some species of HRF remains to be determined.
MCAF may play an important role in the pathogenesis of allergic inflammation. Although the effect of MCAF on human mast cells is not yet known, basophils appear to play a significant role in the pathogenesis of late phase allergic reactions. The mediator release profile indicates the presence of histamine but not PGD2 in the late phase reaction (20) . Mast cells produce both histamine and PGD2, while basophils synthesize histamine but not PGD2 (20) . The latter observation points to the participation of basophils but not mast cells in the late allergic reaction. HRF-like molecules have been detected in the blister fluid from late phase cutaneous allergic reactions (21) , bronchoalveolar lavage fluid (22) , and nasal washings (8) . Increased synthesis of HRF by mononuclear cells has been reported in asthma (23) and atopic dermatitis with food allergy (24) . Availability of an ELISA for MCAF in the near future will help establish the validity of the foregoing observations, and delineate the importance of this cytokine in allergic and other chronic inflammatory diseases.
